List of Chapters/Sections(Table Of Content)
1 Injection Influenza Vaccine Market Overview
1.1 Product Overview and Scope of Injection Influenza Vaccine
1.2 Injection Influenza Vaccine Segment by Type
1.2.1 Global Injection Influenza Vaccine Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Injection Influenza Vaccine Segment by Application
1.3.1 Global Injection Influenza Vaccine Sales Comparison by Application: (2022-2028)
1.3.2 6 Months to 3 Years
1.3.3 > 3 Years
1.4 Global Injection Influenza Vaccine Market Size Estimates and Forecasts
1.4.1 Global Injection Influenza Vaccine Revenue 2017-2028
1.4.2 Global Injection Influenza Vaccine Sales 2017-2028
1.4.3 Injection Influenza Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Injection Influenza Vaccine Market Competition by Manufacturers
2.1 Global Injection Influenza Vaccine Sales Market Share by Manufacturers (2017-2022)
2.2 Global Injection Influenza Vaccine Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Injection Influenza Vaccine Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Injection Influenza Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Injection Influenza Vaccine Market Competitive Situation and Trends
2.5.1 Injection Influenza Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Injection Influenza Vaccine Players Market Share by Revenue
2.5.3 Global Injection Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Injection Influenza Vaccine Retrospective Market Scenario by Region
3.1 Global Injection Influenza Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Injection Influenza Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Injection Influenza Vaccine Market Facts & Figures by Country
3.3.1 North America Injection Influenza Vaccine Sales by Country
3.3.2 North America Injection Influenza Vaccine Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Injection Influenza Vaccine Market Facts & Figures by Country
3.4.1 Europe Injection Influenza Vaccine Sales by Country
3.4.2 Europe Injection Influenza Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Injection Influenza Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Injection Influenza Vaccine Sales by Region
3.5.2 Asia Pacific Injection Influenza Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Injection Influenza Vaccine Market Facts & Figures by Country
3.6.1 Latin America Injection Influenza Vaccine Sales by Country
3.6.2 Latin America Injection Influenza Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Injection Influenza Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Injection Influenza Vaccine Sales by Country
3.7.2 Middle East and Africa Injection Influenza Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Injection Influenza Vaccine Historic Market Analysis by Type
4.1 Global Injection Influenza Vaccine Sales Market Share by Type (2017-2022)
4.2 Global Injection Influenza Vaccine Revenue Market Share by Type (2017-2022)
4.3 Global Injection Influenza Vaccine Price by Type (2017-2022)
5 Global Injection Influenza Vaccine Historic Market Analysis by Application
5.1 Global Injection Influenza Vaccine Sales Market Share by Application (2017-2022)
5.2 Global Injection Influenza Vaccine Revenue Market Share by Application (2017-2022)
5.3 Global Injection Influenza Vaccine Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Sanofi Injection Influenza Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.2.4 CSL Injection Influenza Vaccine Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.3.4 GSK Injection Influenza Vaccine Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Corporation Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Viatris Injection Influenza Vaccine Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.5.4 AstraZeneca Injection Influenza Vaccine Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Hualan Bio
6.6.1 Hualan Bio Corporation Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Hualan Bio Injection Influenza Vaccine Product Portfolio
6.6.5 Hualan Bio Recent Developments/Updates
6.7 Changchun Institute of Biological
6.6.1 Changchun Institute of Biological Corporation Information
6.6.2 Changchun Institute of Biological Description and Business Overview
6.6.3 Changchun Institute of Biological Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Changchun Institute of Biological Injection Influenza Vaccine Product Portfolio
6.7.5 Changchun Institute of Biological Recent Developments/Updates
6.8 Sinovac
6.8.1 Sinovac Corporation Information
6.8.2 Sinovac Description and Business Overview
6.8.3 Sinovac Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Sinovac Injection Influenza Vaccine Product Portfolio
6.8.5 Sinovac Recent Developments/Updates
6.9 Jiangsu GDK
6.9.1 Jiangsu GDK Corporation Information
6.9.2 Jiangsu GDK Description and Business Overview
6.9.3 Jiangsu GDK Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Jiangsu GDK Injection Influenza Vaccine Product Portfolio
6.9.5 Jiangsu GDK Recent Developments/Updates
6.10 KM Biologics
6.10.1 KM Biologics Corporation Information
6.10.2 KM Biologics Description and Business Overview
6.10.3 KM Biologics Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.10.4 KM Biologics Injection Influenza Vaccine Product Portfolio
6.10.5 KM Biologics Recent Developments/Updates
7 Injection Influenza Vaccine Manufacturing Cost Analysis
7.1 Injection Influenza Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Injection Influenza Vaccine
7.4 Injection Influenza Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Injection Influenza Vaccine Distributors List
8.3 Injection Influenza Vaccine Customers
9 Injection Influenza Vaccine Market Dynamics
9.1 Injection Influenza Vaccine Industry Trends
9.2 Injection Influenza Vaccine Market Drivers
9.3 Injection Influenza Vaccine Market Challenges
9.4 Injection Influenza Vaccine Market Restraints
10 Global Market Forecast
10.1 Injection Influenza Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Injection Influenza Vaccine by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Injection Influenza Vaccine by Type (2023-2028)
10.2 Injection Influenza Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Injection Influenza Vaccine by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Injection Influenza Vaccine by Application (2023-2028)
10.3 Injection Influenza Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Injection Influenza Vaccine by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Injection Influenza Vaccine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
